9 Reasons to Buy Pfizer in 2018 and 1 Big One Not To Post author:Sam Post published:December 21, 2017 Post category:BioPharma Pfizer may be the surprise strong-growth stock for next year. Source: BioSpace You Might Also Like Alnylam Significantly Expands Patent Portfolio With New Allowances From United States Patent And Trademark Office June 11, 2017 Stoke Therapeutics Comes Out of Seed Mode With $40M and Ex-Sarepta CEO at Its Helm January 3, 2018 Poor Mid-Stage Results Sink AbbVie’s Plans for Cancer Drug March 21, 2018
Alnylam Significantly Expands Patent Portfolio With New Allowances From United States Patent And Trademark Office June 11, 2017
